Prepare for the CAMLPR Chemistry Test. Enhance your understanding with interactive quizzes, flashcards, and detailed explanations. Boost your confidence and readiness for exam success!

Multiple Choice

Which disorder typically presents with a sharp monoclonal spike in the gamma region and hyperviscosity?

A monoclonal IgM protein causing high blood viscosity is the hallmark of Waldenström's macroglobulinemia. In this disorder the malignant clone is a lymphoplasmacytic cell that overproduces IgM, a very large antibody. When IgM is present in large amounts, the serum becomes thick, leading to hyperviscosity. That viscosity issue explains the classic symptoms: blurred vision or visual changes, mucosal bleeding, headaches, dizziness, and neurologic complaints, especially in advanced cases. The sharp M-spike seen on protein electrophoresis reflects the monoclonal IgM rise driving these effects. Other conditions have different patterns: multiple myeloma typically features IgG or IgA with bone lesions and related symptoms rather than viscosity issues; MGUS involves a small, asymptomatic M-protein without hyperviscosity or end-organ damage; CLL is a leukemia with lymphocytosis and is not primarily defined by an IgM-driven hyperviscosity process.

A monoclonal IgM protein causing high blood viscosity is the hallmark of Waldenström's macroglobulinemia. In this disorder the malignant clone is a lymphoplasmacytic cell that overproduces IgM, a very large antibody. When IgM is present in large amounts, the serum becomes thick, leading to hyperviscosity. That viscosity issue explains the classic symptoms: blurred vision or visual changes, mucosal bleeding, headaches, dizziness, and neurologic complaints, especially in advanced cases. The sharp M-spike seen on protein electrophoresis reflects the monoclonal IgM rise driving these effects.

Other conditions have different patterns: multiple myeloma typically features IgG or IgA with bone lesions and related symptoms rather than viscosity issues; MGUS involves a small, asymptomatic M-protein without hyperviscosity or end-organ damage; CLL is a leukemia with lymphocytosis and is not primarily defined by an IgM-driven hyperviscosity process.